MedTrace Logo

Fiber Tolerability in Children Aged 3-7 Year

NCT02677090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2016-03-10

No results posted yet for this study

Summary

Determination of the digestive tolerability of the PROMITOR® in children from 3 to 7 years old.

Conditions

  • Signs and Symptoms, Digestive

Interventions

DRUG

Placebo (including Maltodextrin)

DRUG

Dose 1 - Promitor®

DRUG

Dose 2 - Promitor®

DRUG

Dose 3 - Promitor®

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02677090 on ClinicalTrials.gov